BDB001-101: Clinical Study of BDB001 as a Mono-therapy or in Combination With Pembrolizumab

NCT03486301 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Tumor, Solid

Interventions

DRUG: BDB001 (EIK1001)
DRUG: Pembrolizumab

Sponsor

Eikon Therapeutics

Collaborators

[object Object]